Skip to main content
. Author manuscript; available in PMC: 2010 Aug 1.
Published in final edited form as: Med Care. 2009 Aug;47(8):866–874. doi: 10.1097/MLR.0b013e3181a31d00

Table 1.

Characteristics of the sample by trial arm: those randomized and those analyzed.

Variable Category Randomized
(N=437)
Analyzed
(N=386)

Nurse Arm
(N=218)
AVR Arm
(N=219)
Nurse Arm
(N=200)
AVR Arm
(N=186)

N(%) N(%) N(%) N(%)
Patient Age 25 ∼ 44 33 (15.14) 31 (14.16) 30 (15.00) 27(14.52)
45 ∼ 54 57 (26.15) 63 (28.77) 55(27.50) 54(29.03)
55 ∼ 64 72 (33.03) 74 (33.79) 64(32.00) 62(33.33)
65 ∼ 74 38 (17.43) 27 (12.33) 34(17.00) 23(12.37)
75 + 18 (8.26) 24 (10.96) 17(8.50) 20(10.75)

Education High school or below 71 (32.57) 67 (30.59) 64(32.00) 57(30.65)

Some college or technical training 72 (33.03) 66 (30.14) 66(33.00) 53(28.49)

College 41 (18.81) 42 (19.18) 40(20.00) 40(21.51)

Graduate professional degree 34 (15.60) 44 (20.09) 30(15.00) 36(19.35)

Cancer Site Colon 30 (13.76) 32 (14.61) 28(14.00) 25(13.44)

Breast 90 (41.28) 87 (39.73) 83(41.50) 77(41.40)

Lung 37 (16.97) 34 (15.53) 32(16.00) 26(13.98)

Other 61 (27.98) 66 (30.14) 57(28.50) 58(31.180

Cancer Stage Early 63 (29.30) 80 (36.70) 59(29.95) 69(37.30)
Late 152 (70.70) 138 (63.30) 138(70.05) 116(62.70)

Cancer Metastasis Yes 128 (58.72) 112 (51.14) 117 (58.50) 92 (49.46)
No 90 (41.28) 107 (48.86) 83 (41.50) 94 (50.54)

Comorbid Conditions 0∼2 139 (63.76) 139 (64.47) 128(64.00) 115(61.83)

3+ 79 (36.24) 80 (36.53) 72(36.00) 71(38.17)

Sex Male 57 (26.15) 53 (24.20) 52 (26.00) 40 (21.51)

Female 161 (73.85) 166 (75.80) 148 (74.00) 146 (78.49)